Form 4: Ovid Therapeutics CBFO Jeffrey Rona Sells Shares to Cover Tax Obligations

Ovid Therapeutics' CBFO, Jeffrey Rona, sold 3,902 shares of common stock on February 26, 2025, at a price of $0.56 per share to cover statutory tax withholding obligations related to vesting restricted stock units.

Summary

• On February 26, 2025, Jeffrey Rona, the CBFO of Ovid Therapeutics Inc., sold 3,902 shares of common stock.
• The sale was executed at a price of $0.56 per share.
• This transaction was conducted to cover statutory tax withholding obligations associated with the vesting of restricted stock units.
• The sale was mandated by Ovid Therapeutics' equity incentive plans, which require a 'sell to cover' transaction to satisfy minimum statutory tax withholding obligations.
• Following the transaction, Jeffrey Rona directly owns 67,973 shares of Ovid Therapeutics Inc.

Sentiment

Score: 5

Explanation: This Form 4 filing reflects a routine transaction (sell to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

There are no forward-looking statements in this document.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares. This particular filing indicates a sale to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an officer could be perceived neutrally by shareholders as it is related to tax obligations and not necessarily a reflection of the officer's view on the company's future performance.

Key Dates